# A Study of AZD4901 in Females With Polycystic Ovary Syndrome

> **NCT01872078** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 67 (actual)

## Conditions studied

- Polycystic Ovary Syndrome (PCOS), Female Endocrine Disorder

## Interventions

- **DRUG:** AZD4901 (oral)
- **DRUG:** Placebo to match AZD4901

## Key facts

- **NCT ID:** NCT01872078
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2015-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01872078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01872078, "A Study of AZD4901 in Females With Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01872078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*